Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.

Alessandro Armuzzi, Luisa Guidi, Livia Biancone, Maria Lia Scribano, Renata D'Inca, Fabiana Castiglione, Claudio Papi, Erika Angelucci, Marco Daperno, Filippo Mocciaro, Gabriele Riegler, Walter Fries, Gianmichele Meucci, Patrizia Alvisi, Luisa Spina, Sandro Ardizzone, Carmelina Petruzziello, Alessandra Ruffa, Anna Kohn, Maurizio VecchiRoberto Di Mitri, Sara Renna, Calabrese Emma, Francesca Rogai, Alessandra Rossi, Ambrogio Orlando, Francesco Pallone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

19 Citazioni (Scopus)


BACKGROUND AND AIMS: Cancer risk in inflammatory bowel disease [IBD] is still debated. In a prospective, multicentre, nested case-control study, we aimed to characterise incident cases of cancer in IBD. The role of immunomodulators vs clinical characteristics of IBD as risk factors for cancer was also investigated. MATERIALS AND METHODS: From January 2012 to December 2014, each IBD patient with incident cancer was matched with two IBD patients without cancer for: IBD type, gender, and age. Risk factors were assessed by multivariate regression analysis. RESULTS: IBD patients considered numbered 44619: 21953 Crohn's disease [CD], 22666 ulcerative colitis [UC]. Cancer occurred in 174 patients: 99 CD [CD-K], 75 UC [UC-K]. Controls included 198 CD [CD-C], 150 UC [UC-C]. Cancer incidence in IBD was 3.9/1000, higher in CD (4.5/1000 [99/21,953]) than in UC (3.3/1000 [75/22,666]; p = 0.042). Cancers involved: digestive system [36.8%], skin [13.2%], urinary tract [12.1%], lung [8.6%], breast [8%], genital tract [6.9%], thyroid [4.6%], lymphoma [3.5%], others [6.3%]. In CD, penetrating behaviour and combined thiopurines and tumour necrosis factor alpha [TNFα] antagonists were risk factors for cancer overall: odds ratio [OR] (95% confidence interval [CI] 2.33 [1.01-5.47]); 1.97 [1.1-3.5]; and for extracolonic cancers 3.9 [1.56-10.1]; 2.15 [1.17-4.1], respectively. In UC, risk factors were pancolitis and disease-related surgery for cancer overall (OR: 2.52 [1.26-5.1]; 5.09 [1.73-17.1]); disease-related surgery for colorectal cancer [CRC] (OR 3.6 [1.0-12]); and extensive and left-sided vs distal UC for extracolonic cancers (OR: 2.55 [1.15-5.9]; 2.6 [1.04-6.6]), respectively. CONCLUSIONS: In a multicentre study, penetrating CD and extensive UC were risk factors for cancer overall. Cancer incidence was higher in CD than in UC.
Lingua originaleEnglish
pagine (da-a)913-924
Numero di pagine12
RivistaJournal of Crohn's and Colitis
Stato di pubblicazionePubblicato - 2016


  • inflammatory bowel disease


Entra nei temi di ricerca di 'Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.'. Insieme formano una fingerprint unica.

Cita questo